Effectiveness, tolerability and safety of opicapone in fluctuating Parkinson's disease

被引：0
|
作者：
Marti-Andres, G. [1 ]
Armengou, L. [1 ]
Esparragosa, I. [1 ]
Toledano Illan, C. [1 ]
Valenti, R. [1 ]
Luquin, R. [1 ]
机构：
[1] Clin Univ Navarra, Neurol, Pamplona, Spain
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1184
引用
收藏
页码：633 / 634
页数：2
相关论文
共 50 条
  • [21] Dyskinesia and adherence to safinamide and opicapone in fluctuating patients with Parkinson's disease: observational retrospective study
    Lorenzo-Barreto, P.
    Parees, I.
    Perez-Torre, P.
    Fanjul, S.
    Lopez-Sendon, J. L.
    Perez-Trapote, F.
    Saez-Marin, A.
    Stiauren-Fernandez, E.
    Patino-Paton, A.
    Martinez-Castrillo, J. C.
    Alonso-Canovas, A.
    MOVEMENT DISORDERS, 2023, 38 : S614 - S615
  • [22] Opicapone for the treatment of Parkinson's disease
    Rodrigues, Filipe B.
    Ferreira, Joaquim J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (04) : 445 - 453
  • [23] Exploratory efficacy of opicapone in fluctuating Parkinson's disease patients at different stages of symptom progression
    Lopes, N.
    Ferreira, J.
    Lees, A.
    Poewe, W.
    Reichmann, H.
    Santos, A.
    Oliveira, C.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2016, 31 : S642 - S643
  • [24] Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
    Beke, M.
    Mackie, P.
    Klann, E.
    Rusch, C.
    Gurrala, A.
    Chua, S.
    Ince, E.
    Almeida, L.
    Ramirez-Zamora, A.
    MOVEMENT DISORDERS, 2021, 36 : S202 - S202
  • [25] Safety and tolerability of rotigotine in advanced Parkinson's disease
    LeWitt, Peter A.
    Lyons, Kelly E.
    Pahwa, Rajesh
    Poewe, Werner
    Rascol, Olivier
    Quinn, Niall
    Tolosa, Eduardo
    Oertel, Wolfgang M.
    Boroojerdi, Babak
    ANNALS OF NEUROLOGY, 2008, 64 : S54 - S55
  • [26] Opicapone Efficacy and Tolerability in Parkinson's Disease Patients Reporting Insufficient Benefit/Failure of Entacapone
    Vokurka, Petr
    Barron, Andrew
    Sumaria, Sheetal
    Stockford, Lindsey
    Jarman, Paul
    Bhatia, Kailash
    Farmer, Simon
    Saifee, Tabish
    Warner, Tom
    Weil, Rimona
    Gandhi, Sonia
    Limousin, Patricia
    Korlipara, Prasad
    Foltynie, Tom
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2020, 7 (08): : 955 - 960
  • [27] Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
    Heinz Reichmann
    Andrew Lees
    José-Francisco Rocha
    Diogo Magalhães
    Patrício Soares-da-Silva
    Translational Neurodegeneration, 9
  • [28] OPICAPONE EFFECT ON SLEEP DISORDERS IN FLUCTUATING PARKINSON'S DISEASE PATIENTS: FINDINGS FROM THE OASIS TRIAL
    Ferreira, J. J.
    Gago, M. F.
    Costa, R.
    Fonseca, M. M. F.
    Almeida, J.
    Rocha, J-F
    Holenz, J.
    Trenkwalder, C.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [29] Activities of daily living and motor scores of the UPDRS in fluctuating Parkinson's disease patients treated with opicapone
    Ferreira, J.
    Lees, A.
    Rascol, O.
    Muller, T.
    Santos, A.
    Oliveira, I.
    Lopes, N.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2016, 31 : S643 - S643
  • [30] Opicapone for the treatment of Parkinson's disease: a review
    Feldman, Matthew
    Margolesky, Jason
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (05) : 532 - 543
12345